Submission Number: 560891-00114
Received: 8/3/2012 2:15:17 PM
Commenter: Nanette Parratto-Wagner
Agency: Federal Trade Commission
Initiative: Request for Comments and Announcement of Workshop on Pet Medications Issues, Project No. P121201
Attachments: No Attachments
• How are pet medications distributed to consumers? - Prescription medications should only be dispensed in response to a valid, written prescription (this may include a faxed prescription)
• What are the business rationales for various pet medication distribution practices? - To provide quality controlled access, thus safety, for consumers, at affordable prices.
• How do these practices affect prices to consumers? - More competition should lower prices.
• How do these practices affect product supply and quality? - Unfortunately, online pharmacies actually reduce access and increase prices for some products, by limiting available suppliers to only a few maga-outlets.
• How do these practices affect entry into the pet medications industry? - Prices may be increased, because smaller manufacturers may either be bought out of the market, or may not be able to compete, or may have increased marketing costs to get access to the mega-outlets.
• What product safety issues exist with respect to these practices? - Limited valid doctor - client - patient interaction. Clients are not educated about risks/benefits of all options available. Counterfeit products have been found, which contain unknown, potentially dangerous substances. Toxicities go unreported.
• Are there other factors that should be considered when analyzing the competition and consumer protection issues related to the distribution of pet medications? - Mega-outlets violate anti-trust laws. Monopolies hurt consumers.